Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1952
https://www.valueinhealthjournal.com/article/S1098-3015(17)32286-6/fulltext
Title : Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32286-6&doi=10.1016/j.jval.2017.08.1952
First page : A724
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1777
Categories :
Tags :
Regions :
ViH Article Tags :